Acute ITP is a benign, self-limiting disease. Chronic ITP is diagnosed when thrombocytopenia persists beyond 12 months. The main objective of the present study was to examine whether absolute lymphocyte counts at diagnosis has predictive value with chronic ITP. A total of 601 patients diagnosed as ITP between 1995 and 2014 were retrospectively evaluated. CBCs with differential counts were performed at presentation for 601 patients. Absolute lymphocyte counts at presentation were independently predictive of disease duration. The male to female ratio was almost 1:1 and 25.9 % (156/601) of the patients had chronic ITP. We determined that age >6.75 year, platelet counts >6.950/mm3 and absolute lymphocyte counts ≤2.050/mm3 was associated with a significant risk for developing chronic ITP. Absolute lymphocyte counts at the time of diagnosis were predictive variables for the development of chronic ITP. Further researches are needed to confirm the current finding and to assess the underlying pathophysiology with the course of the ITP in observational studies.
Keywords: Absolute lymphocyte counts; Child; ITP.
Conflict of interest statement
No financial and commercial conflict of interest.
Initial lymphocyte count and the development of persistent/chronic immune thrombocytopenic purpura.Pediatr Blood Cancer. 2010 Sep;55(3):508-11. doi: 10.1002/pbc.22570. Pediatr Blood Cancer. 2010. PMID: 20658623
Absolute lymphocyte counts as prognostic indicators for immune thrombocytopenia outcomes in children.Pediatr Blood Cancer. 2013 Dec;60(12):1967-74. doi: 10.1002/pbc.24628. Epub 2013 Aug 29. Pediatr Blood Cancer. 2013. PMID: 24038723
Clinical course and prognostic factors of childhood immune thrombocytopenia: single center experience of 10 years.Korean J Pediatr. 2016 Aug;59(8):335-40. doi: 10.3345/kjp.2016.59.8.335. Epub 2016 Aug 24. Korean J Pediatr. 2016. PMID: 27610182 Free PMC article.
Childhood immune thrombocytopenia: Clinical presentation and management.Sudan J Paediatr. 2012;12(1):27-39. Sudan J Paediatr. 2012. PMID: 27493327 Free PMC article. Review.
Spotlight on romiplostim in the treatment of children with chronic immune thrombocytopenia: design, development, and potential place in therapy.Drug Des Devel Ther. 2017 Mar 30;11:1055-1063. doi: 10.2147/DDDT.S113191. eCollection 2017. Drug Des Devel Ther. 2017. PMID: 28408804 Free PMC article. Review.
Cited by 1 article
Platelet-to-Lymphocyte Ratio (PLR) Is Associated with Immune Thrombocytopenia (ITP) Recurrence: A Retrospective Cohort Study.Med Sci Monit. 2019 Nov 18;25:8683-8693. doi: 10.12659/MSM.917531. Med Sci Monit. 2019. PMID: 31735908 Free PMC article.